Results 31 to 40 of about 224,807 (304)

Method of treatment for prostate cancer with androgen receptor antagonists and glucocorticoid receptor antagonists [PDF]

open access: yes, 2023
Methods are directed to the treatment of subjects with prostate cancer, in particular those with castration resistant prostate cancer, with glucocorticoid receptor antagonists.

core  

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

open access: yesiScience, 2021
Summary: Epidemiological data showing increased severity and mortality of COVID-19 in men suggests a potential role for androgen in SARS-CoV-2 infection.
Qu Deng   +4 more
doaj   +1 more source

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer

open access: yesCell Death and Disease, 2022
Androgen receptor (AR) plays an important role in the progression of prostate cancer and has been targeted by castration or AR-antagonists. The emergence of castration-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT) is ...
Xuanrong Chen   +10 more
doaj   +1 more source

Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer [PDF]

open access: yes, 2001
Objective To examine the role of androgen receptor (AR) gene amplification and aneusomy of the X chromosome in the development of antiandrogen-resistant prostate cancer.
Watters, A.D.   +5 more
core   +1 more source

Transcriptional regulation of prostate kallikrein-like genes by androgen. [PDF]

open access: yes, 1992
Using gene-specific synthetic oligonucleotides the expression and regulation of kallikrein-like genes in the human prostatic cancer cell line LNCaP were studied.
Schulz, Peter   +2 more
core   +1 more source

Design and Synthesis of 4‑(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists

open access: yes, 2016
We report the design and synthesis of novel 4-(4-benzoylaminophenoxy)­phenol derivatives that bind to the androgen receptor (AR) ligand-binding domain and exhibit potent androgen-antagonistic activity.
Shuichi Mori (362273)   +3 more
core   +2 more sources

Mixture effects at very low doses with combinations of anti-androgenic pesticides, antioxidants, industrial pollutant and chemicals used in personal care products [PDF]

open access: yes, 2014
This article has been made available through the Brunel Open Access Publishing Fund.Many xenobiotics have been identified as in vitro androgen receptor (AR) antagonists, but information about their ability to produce combined effects at low ...
Rosivatz, Erika   +11 more
core   +1 more source

The androgen receptor-targeted proteolysis targeting chimera and other alternative therapeutic choices in overcoming the resistance to androgen deprivation treatment in prostate cancer [PDF]

open access: yes, 2022
\ua9 2022, The Author(s).Androgen receptor (AR) plays a vital role in prostate cancer (PCa), including castration-resistant PCa, by retaining AR signalling. Androgen deprivation treatment (ADT) has been the standard treatment in the past decades. A great
Li L, Xu J
core   +3 more sources

The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium [PDF]

open access: yes, 2008
Progesterone is indispensable for differentiation of human endometrial stromal cells (HESCs) into decidual cells, a process that critically controls embryo implantation.
Cartwright, JE   +44 more
core   +1 more source

Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting [PDF]

open access: yesInvestigative and Clinical Urology, 2020
Purpose: This study aimed to evaluate the clinical efficacy of enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients using real-world data from Korean patients.
Seung Il Jung   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy